Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 6/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.62 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.55 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.55 |
| ▸ | PLA2G5 | P39877 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.52 |
| ▸ | ACER2 | Q5QJU3 | 1/20 | 0.52 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.51 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.51 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.51 |
| ▸ | ASAH2 | Q9NR71 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5667184 | 1.00 | FAAH (0.62) | FAAHMEN1KMT2AMAPK1NOD1 | |
| SCHEMBL17204243 | 1.00 | FAAH (0.62) | FAAHMEN1KMT2AMAPK1NOD1 | |
| SCHEMBL543568 | 1.00 | FAAH (0.62) | FAAHMEN1KMT2AMAPK1NOD1 | |
| SCHEMBL17203963 | 1.00 | FAAH (0.62) | FAAHMEN1KMT2AMAPK1NOD1 | |
| SCHEMBL8823482 | 1.00 | FAAH (0.62) | FAAHMEN1KMT2AMAPK1NOD1 | |
| SCHEMBL7268170 | 1.00 | FAAH (0.62) | FAAHMEN1KMT2AMAPK1NOD1 | |
| SCHEMBL25196976 | 1.00 | FAAH (0.62) | FAAHMEN1KMT2AMAPK1NOD1 | |
| SCHEMBL11047279 | 1.00 | FAAH (0.62) | FAAHMEN1KMT2AMAPK1NOD1 | |
| SCHEMBL7269318 | 1.00 | FAAH (0.62) | FAAHMEN1KMT2AMAPK1NOD1 | |
| SCHEMBL11047281 | 1.00 | FAAH (0.62) | FAAHMEN1KMT2AMAPK1NOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8097584-B2 | Therapeutic mixture comprising insulin, ethylenediamine and an antimicrobial preservative; improved chemical and storage stability | NOVO NORDISK A/S (DK) | 2012-01-17 | — | — | US | claimed |
| US-5616552-A | FOAM MAINTENANCE AND QUALITY; NONIRRITATING TO SKIN AND HAIR | AJINOMOTO CO., INC. (JP) | 1997-04-01 | — | — | US | claimed |
| EP-4662197-A1 | METHOD FOR PURIFICATION OF AMINO ACID SURFACTANTS | BASF SE (DE) | 2025-12-17 | — | — | EP | disclosed |
| CN-113993565-B | Injection device with filling level indicator | 赛诺菲 | 2025-04-25 | — | — | CN | disclosed |
| CN-115431458-B | Elastomeric article with embedded electronics and method of making the same | 西医药服务有限公司 | 2025-04-01 | — | — | CN | disclosed |
| CN-113993561-B | Injection device | 赛诺菲 | 2025-03-11 | — | — | CN | disclosed |
| CN-115025324-B | Sensor for a drug delivery device | 赛诺菲-安万特德国有限公司 | 2025-01-24 | — | — | CN | disclosed |
| WO-2024165426-A1 | METHOD FOR PURIFICATION OF AMINO ACID SURFACTANTS | BASF SE (DE) | 2024-08-15 | — | — | WO | disclosed |
| EP-4414360-A1 | METHOD FOR PURIFICATION OF AMINO ACID SURFACTANTS | BASF SE (DE) | 2024-08-14 | — | — | EP | disclosed |
| CN-118284398-A | Cleaning agent composition | 味之素株式会社 | 2024-07-02 | — | — | CN | disclosed |
| EP-3677275-B1 | COMBINATION OF AN INSULIN AND A GLP-1 AGONIST | SANOFI AVENTIS DEUTSCHLAND (DE) | 2024-06-12 | — | — | EP | disclosed |
| WO-2023090455-A1 | DETERGENT COMPOSITION | 味の素株式会社 | 2023-05-25 | — | — | WO | disclosed |
| CN-107308442-B | Pharmaceutical composition comprising a GLP-1 agonist, insulin and methionine | 赛诺菲-安万特德国有限公司 | 2022-10-18 | — | — | CN | disclosed |
| CN-104955472-A | Fatty acid acylated amino acids for growth hormone delivery | NOVO NORDISK HEALTHCARE AG | 2015-09-30 | — | — | CN | disclosed |
| US-20150250882-A1 | Fatty Acid Acylated Amino Acids for Growth Hormone Delivery | NOVO NORDISK HEALTHCARE AG (CH) | 2015-09-10 | — | — | US | disclosed |
| EP-2908845-A1 | FATTY ACID ACYLATED AMINO ACIDS FOR GROWTH HORMONE DELIVERY | Novo Nordisk Health Care AG (CH) | 2015-08-26 | — | — | EP | disclosed |
| WO-2014060512-A1 | FATTY ACID ACYLATED AMINO ACIDS FOR GROWTH HORMONE DELIVERY | NOVO NORDISK HEALTH CARE AG (CH) | 2014-04-24 | — | — | WO | disclosed |
| US-8097584-B2 | Therapeutic mixture comprising insulin, ethylenediamine and an antimicrobial preservative; improved chemical and storage stability | NOVO NORDISK A/S (DK) | 2012-01-17 | — | — | US | disclosed |
| US-5616552-A | FOAM MAINTENANCE AND QUALITY; NONIRRITATING TO SKIN AND HAIR | AJINOMOTO CO., INC. (JP) | 1997-04-01 | — | — | US | disclosed |
| EP-0687721-A2 | Detergent composition | Ajinomoto Co., Inc. (JP) | 1995-12-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150250882-A1 | Fatty Acid Acylated Amino Acids for Growth Hormone Delivery | GHRHR, GHSR, GHITM | FAAH 53/4885MEN1 2160/4885KMT2A 712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.